LNAI
Lunai Bioworks Inc. NASDAQ Listed Sep 30, 2025$2.22
-0.89%
vs $2.24
Mkt Cap $10.1M
52w Low $1.21
5.1% of range
52w High $21.20
50d MA $2.75
200d MA $4.73
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-0.5x
ROE
1273.6%
P/FCF
-4.7x
RSI (14)
49.60
ATR (14)
$0.34
Beta
0.49
50d MA
$2.75
200d MA
$4.73
Avg Volume
339.2K
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
2080 Century Park East · Los Angeles, CA 90067 · US
Data updated apr 25, 2026 7:28pm
· Source: financialmodelingprep.com